IQVIA HOLDINGS INC. Restructuring Reserve, Translation and Other Adjustment
IQVIA HOLDINGS INC. (IQV) reported Restructuring Reserve, Translation and Other Adjustment of -$1.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-15.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveTranslationAndOtherAdjustment · last filed 2023-02-15
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for the quarter ending 2021-09-30 was -$1.00M, a 150.00% decline year-over-year.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for the quarter ending 2021-06-30 was $1.00M.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for the quarter ending 2021-03-31 was -$2.00M.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for fiscal 2022 was -$1.00M.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for fiscal 2021 was -$2.00M, a 200.00% decline from fiscal 2020.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for fiscal 2020 was $2.00M.
- IQVIA HOLDINGS INC. restructuring reserve, translation and other adjustment for fiscal 2019 was -$9.00M, a 325.00% decline from fiscal 2018.
| Period end | Restructuring Reserve, Translation and Other Adjustment 3 month | Restructuring Reserve, Translation and Other Adjustment 6 month | Restructuring Reserve, Translation and Other Adjustment 9 month | Restructuring Reserve, Translation and Other Adjustment 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$1.00M 10-K · filed 2023-02-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$1.00M derived: sum of 2 quarters · filed 2023-02-15 | $0.00 derived: sum of 3 quarters · filed 2023-02-15 | -$2.00M 10-K · filed 2023-02-15 |
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $0.00 derived: sum of 2 quarters · filed 2021-10-22 | -$2.00M 10-Q · filed 2021-10-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$1.00M 10-Q · filed 2021-07-28 | $1.00M derived: sum of 3 quarters · filed 2022-02-16 | $3.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2021-03-31 | -$2.00M 10-Q · filed 2021-04-23 | $0.00 derived: sum of 2 quarters · filed 2022-02-16 | $2.00M derived: sum of 3 quarters · filed 2022-02-16 | $0.00 derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $4.00M derived: sum of 2 quarters · filed 2022-02-16 | $2.00M derived: sum of 3 quarters · filed 2022-02-16 | $2.00M 10-K · filed 2022-02-16 |
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $0.00 derived: sum of 2 quarters · filed 2020-10-22 | $0.00 10-Q · filed 2020-10-22 | $2.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2020-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | -$2.00M 10-Q · filed 2020-07-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | -$2.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 | $2.00M derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | -$9.00M 10-K · filed 2021-02-12 |
| 2019-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$2.00M derived: sum of 2 quarters · filed 2019-11-01 | -$11.00M 10-Q · filed 2019-11-01 | -$6.00M derived: sum of 4 quarters · filed 2020-02-18 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$9.00M 10-Q · filed 2019-07-24 | -$4.00M derived: sum of 3 quarters · filed 2020-02-18 | -$4.00M derived: sum of 4 quarters · filed 2020-02-18 |
| 2019-03-31 | -$9.00M 10-Q · filed 2019-05-02 | -$4.00M derived: sum of 2 quarters · filed 2020-02-18 | -$4.00M derived: sum of 3 quarters · filed 2020-02-18 | -$7.00M derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $5.00M derived: sum of 2 quarters · filed 2020-02-18 | $2.00M derived: sum of 3 quarters · filed 2020-02-18 | $4.00M 10-K · filed 2020-02-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$3.00M derived: sum of 2 quarters · filed 2018-10-25 | -$1.00M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$1.00M 10-Q · filed 2018-07-27 | ||
| 2018-03-31 | $2.00M 10-Q · filed 2018-05-04 | |||
| 2017-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $4.00M derived: sum of 2 quarters · filed 2017-10-27 | $1.00M 10-Q · filed 2017-10-27 | -$2.97M derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $2.00M 10-Q · filed 2017-08-04 | -$1.97M derived: sum of 3 quarters · filed 2018-02-16 | -$2.07M derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-03-31 | -$3.00M 10-Q · filed 2017-05-08 | -$6.97M derived: sum of 2 quarters · filed 2018-02-16 | -$7.07M derived: sum of 3 quarters · filed 2018-02-16 | -$7.69M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-12-31 | -$3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$4.07M derived: sum of 2 quarters · filed 2018-02-16 | -$4.69M derived: sum of 3 quarters · filed 2018-02-16 | -$5.00M 10-K · filed 2018-02-16 |
| 2016-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$723.00K derived: sum of 2 quarters · filed 2016-11-03 | -$1.03M 10-Q · filed 2016-11-03 | -$1.11M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | -$619.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | -$927.00K 10-Q · filed 2016-07-27 | -$1.00M derived: sum of 3 quarters · filed 2016-07-27 | |
| 2016-03-31 | -$308.00K 10-Q · filed 2016-05-03 | -$386.00K derived: sum of 2 quarters · filed 2016-05-03 | ||
| 2015-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $395.00K 10-K · filed 2016-02-11 | ||
| 2015-09-30 | $473.00K 10-Q · filed 2015-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |